Splice site type | Wild type sequence | CV | Mutant type sequence | CV | Variation (%) | |||||
atcataagt |
| atcgtaagt |
| 32.2 % |
Data for this mutation
Sample ID | MSH6 | MLH1 | MSH2 | MUTYH | APC |
---|---|---|---|---|---|
41_HNPCC611120130005 | - | - | - | - | - |
Analysis | Result | Date | Origin | PMID/dbSNP |
---|---|---|---|---|
MMR function in tumor cells | MSH2-MSH6- (HNPCC611-1) | 13/06/14 | 41 (HEGP) | |
Clinical phenotype | Multiple late-onset Lynch-related cancers (HNPCC611) | 13/06/14 | 41 (HEGP) | |
In vitro analysis | RT-PCR (PAXgene) : normal splicing (biallelic expression) | 25/09/15 | 19 (INSERM U1079-Rouen) |
Biological significance | Date | Comment |
---|---|---|
Neutral | 25/09/15 | --- |